The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Interventions for structural heart disease
TAVI for low-flow, low-gradient severe aortic stenosis with preserved or reduced ejection fraction: a subgroup analysis from the German Aortic Valve Registry (GARY)
Alexander Lauten1*, MD; Hans R. Figulla2, MD; Helge Möllmann2, MD; David Holzhey3, MD; Joachim Kötting4, MSc; Andreas Beckmann5, MD; Christof Veit4, MD; Jochen Cremer6, MD; Karl-Heinz Kuck7, MD; Rüdiger Lange8, MD; Ralf Zahn9, MD; Stefan Sack10, MD; Gerhard Schuler3, MD; Thomas Walther11, MD; Friedhelm Beyersdorf
1. Department of Internal Medicine I, University Heart Center Jena, Jena, Germany; 2. Department of Cardiology, Kerckhoff-Klinik, Bad Nauheim, Germany; 3. Leipzig Heart Center, University of Leipzig, Leipzig, Germany; 4. BQS Institute for Quality and Pati
Aims: The study analyses the outcome of patients undergoing transcatheter aortic valve implantation (TAVI) for different subtypes of severe aortic stenosis (AS) based on data from the GAR